Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Cost analysis of protease inhibitor therapy in HIV infection in Canada

    • 6 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Cost analysis of protease inhibitor therapy in HIV infection in Canada. Pharmacoecon. Outcomes News 168, 9 (1998). https://doi.org/10.1007/BF03284917

    Download citation

    Keywords

    • Nucleoside Analogue
    • Dual Therapy
    • Plasma Viral Load
    • Drug Treatment Programme
    • Average Annual Cost